Market Overview

Premier Inc. Partners with Progknowse, Inc. to Develop Precision Medicine Analytics

Share:
  • Integration of outcomes and genomic data within PremierConnect®
    offers large-scale, national data set for research and personalized
    care.
  • Developing algorithms that support precise, actionable
    therapeutic recommendations.

Premier Inc. (NASDAQ:PINC), a healthcare improvement company, is
partnering with Progknowse, Inc. to develop a clinical and genomic data
set for use within the PremierConnect® performance
improvement platform to develop new predictive analytics capabilities
that support precision medicine and personalized care delivery.

Premier and Progknowse plan to work with leading research universities
and data scientists to develop real-time predictive algorithms that can
be used by individual health systems to support care interventions for
patients with specific genetic markers.

Progknowse, a startup predictive analytics firm recently founded by
former Inova Health System Chief Technology Officer, Marshall Ruffin,
MD, will utilize the PremierConnect platform to access national data
sets that include de-identified clinical outcomes data on approximately
45 percent of all patient discharges in the U.S. Progknowse will access
this data within a secure development space, which can be leveraged by
data scientists to create predictive algorithms that advance and
personalize treatment based on specific genetic information.

"Today, only the most technologically advanced health systems are
conducting precision medicine research, and even then, their view is
often limited to their specific populations," said Leigh Anderson,
President of Performance Services at Premier. "This partnership combines
the skills and resources necessary to access data sets and genomic
information to create a much broader, national healthcare database for
data scientists to analyze. Once developed, the resulting output is
expected to allow us to offer discrete analytics as a syndicated service
to our members, putting precision medicine within the reach of almost
any health system, regardless of size and budget. If successful, we
believe this will effectively eliminate the need to make large
investments in home-grown solutions, all with the goal of better serving
patients."

In their work with researchers and data scientists from several major
universities, Premier and Progknowse plan to create the first set of
predictive algorithms on precise, actionable therapeutic recommendations
for improving and personalizing care delivery.

"One of the biggest challenges facing precision medicine efforts is the
need for massive amounts of clinical data," said Brett Beaulieu-Jones,
PhD, co-founder of Progknowse and Research Fellow in Biomedical
Informatics at Harvard Medical School. "Not only does this include
genomic sequencing information for a large population, but also
treatment variables housed within the EMR and their connections to
longitudinal cost and quality outcomes. Working with Premier and
Progknowse, we will develop and have access to an extensive predictive
data source with algorithms that will enable us to better understand the
progression of certain diseases, how they affect specific patient
populations and how providers can better intervene for more successful
long-term outcomes."

Dr. Ruffin founded Progknowse with the vision of enabling precision
medicine to improve healthcare outcomes.

"As a former health system chief technology officer and user of the
PremierConnect platform, I believe that Premier is the only organization
that can help Progknowse realize our vision," Dr. Ruffin said. "No one
health system can produce the volume of data needed to conduct this
work, and as a national alliance and trusted partner to health systems,
Premier has an unparalleled track record as a trusted source of
integrated data and insights that help health systems innovate and make
leaps forward in care delivery. I am extremely excited about this
partnership and the advances in patient care that we expect to make."

The financial terms of the Progknowse partnership were not disclosed and
is not expected to have any impact on Premier's fiscal 2019 financial
results.

Forward-looking statements

Matters discussed in this release that are not statements of historical
or current facts, such as the ability to develop new predictive
analytics capabilities and Premier's ability to commercialize and
syndicate such capabilities, as discussed herein, are "forward-looking
statements" within the meaning +of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements may involve known and
unknown risks, uncertainties and other factors that may cause the actual
results, performance or achievements of Premier to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking statements.
Accordingly, readers should not place undue reliance on any
forward-looking statements. In addition to statements that explicitly
describe such risks and uncertainties, readers are urged to consider
statements in the conditional or future tenses or that include terms
such as "believes," "belief," "expects," "estimates," "intends,"
"anticipates" or "plans" to be uncertain and forward-looking.
Forward-looking statements may include comments as to Premier's beliefs
and expectations as to future events and trends affecting its business
and are necessarily subject to uncertainties, many of which are outside
Premier's control. More information on potential factors that could
affect Premier's financial results is included from time to time in the
"Forward-Looking Statements," "Risk Factors" and "Management's
Discussion and Analysis of Financial Condition and Results of
Operations" sections of Premier's periodic and current filings with the
SEC and available on Premier's website at investors.premierinc.com.
Forward-looking statements speak only as of the date they are made.
Premier undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise that occur after that date.

About Progknowse, Inc.

Based in Tysons, Va., Progknowse, Inc. is an early stage precision
medicine technology company that seeks to produce predictive analytics
with state-of-the-art algorithms using machine learning.

About Premier Inc.

Premier Inc. (NASDAQ:PINC) is a leading healthcare improvement company,
uniting an alliance of approximately 3,900 U.S. hospitals and 150,000
other provider organizations. With integrated data and analytics,
collaboratives, supply chain solutions, and advisory and other services,
Premier enables better care and outcomes at a lower cost. Premier, a
Malcolm Baldrige National Quality Award recipient, plays a critical role
in the rapidly evolving healthcare industry, collaborating with members
to co-develop long-term innovations that reinvent and improve the way
care is delivered to patients nationwide. Headquartered in Charlotte,
N.C., Premier is passionate about transforming American healthcare.
Please visit Premier's news and investor sites on www.premierinc.com.

View Comments and Join the Discussion!